Polish (WIG) Clinical Research and Equipment Industry Analysis
UpdatedMay 24, 2024
DataAggregated Company Financials
Companies5
- 7D0.2%
- 3M5.1%
- 1Y-8.7%
- YTDn/a
The Clinical Research and Equipment industry is up 5.0% in the last week, with Ryvu Therapeutics up 11%. In contrast, the industry has lost 8.7% in the last 12 months. Looking forward, earnings are expected to remain mostly flat in the next few years.
Industry Valuation and Performance
Has the Polish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 24 May 2024 | zł2.6b | zł413.5m | -zł32,092,283.00 | 20.2x | -81.8x | 6.3x |
| Sun, 21 Apr 2024 | zł2.6b | zł421.0m | -zł26,364,957.00 | 18.4x | -98x | 6.1x |
| Tue, 19 Mar 2024 | zł2.5b | zł478.9m | -zł71,866,957.00 | 45.5x | -35.2x | 5.3x |
| Thu, 15 Feb 2024 | zł2.5b | zł494.7m | -zł51,178,957.00 | 45x | -49.8x | 5.1x |
| Sat, 13 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 47.3x | -49.5x | 5x |
| Mon, 11 Dec 2023 | zł2.5b | zł495.2m | -zł50,454,191.00 | 45.2x | -49.5x | 5x |
| Wed, 08 Nov 2023 | zł2.6b | zł512.0m | -zł37,354,934.00 | 31.7x | -68.3x | 5x |
| Fri, 06 Oct 2023 | zł2.8b | zł515.2m | -zł43,569,514.00 | 39.9x | -63.9x | 5.4x |
| Sun, 03 Sep 2023 | zł2.8b | zł507.8m | -zł51,598,105.00 | 42.7x | -53.9x | 5.5x |
| Tue, 01 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 46.8x | -46.8x | 5.6x |
| Thu, 29 Jun 2023 | zł2.7b | zł512.4m | -zł61,559,268.00 | 42.8x | -44.4x | 5.3x |
| Sat, 27 May 2023 | zł2.9b | zł507.5m | -zł59,821,034.00 | 46.9x | -48.6x | 5.7x |
| Mon, 24 Apr 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 67.2x | -43.3x | 5.6x |
| Wed, 22 Mar 2023 | zł3.2b | zł473.8m | -zł77,860,781.00 | 74.9x | -40.5x | 6.7x |
| Fri, 17 Feb 2023 | zł3.0b | zł475.0m | -zł78,933,423.00 | 81.4x | -37.7x | 6.3x |
| Sun, 15 Jan 2023 | zł3.1b | zł483.0m | -zł79,277,613.00 | 62.4x | -38.9x | 6.4x |
| Tue, 13 Dec 2022 | zł2.7b | zł464.9m | -zł87,461,643.00 | 59.2x | -30.5x | 5.7x |
| Thu, 10 Nov 2022 | zł2.3b | zł445.7m | -zł96,033,392.00 | 57.5x | -23.8x | 5.1x |
| Sat, 08 Oct 2022 | zł2.4b | zł443.7m | -zł83,357,892.00 | 63.2x | -28.4x | 5.3x |
| Mon, 05 Sep 2022 | zł2.0b | zł409.8m | -zł84,484,453.00 | 59.2x | -24.1x | 5x |
| Wed, 03 Aug 2022 | zł2.1b | zł417.3m | -zł76,832,012.00 | 58.3x | -27.5x | 5.1x |
| Fri, 01 Jul 2022 | zł1.7b | zł417.3m | -zł76,832,012.00 | 49.7x | -22.5x | 4.1x |
| Sun, 29 May 2022 | zł2.0b | zł392.6m | -zł74,127,317.00 | 48x | -26.9x | 5.1x |
| Tue, 26 Apr 2022 | zł2.3b | zł383.1m | -zł63,046,404.00 | 51.1x | -36.3x | 6x |
| Thu, 24 Mar 2022 | zł2.1b | zł327.3m | -zł66,400,347.00 | 55.5x | -32.2x | 6.5x |
| Sat, 19 Feb 2022 | zł2.3b | zł316.7m | -zł60,433,049.00 | 60x | -38.7x | 7.4x |
| Mon, 17 Jan 2022 | zł2.8b | zł310.5m | -zł60,562,303.00 | 70x | -45.5x | 8.9x |
| Wed, 15 Dec 2021 | zł2.8b | zł310.5m | -zł60,562,303.00 | 69.3x | -45.8x | 8.9x |
| Fri, 12 Nov 2021 | zł2.7b | zł256.7m | -zł41,621,781.00 | 43x | -65.6x | 10.6x |
| Sun, 10 Oct 2021 | zł2.6b | zł256.7m | -zł41,621,781.00 | 41.1x | -62.1x | 10.1x |
| Tue, 07 Sep 2021 | zł2.6b | zł222.6m | -zł34,840,889.00 | 31.8x | -74.1x | 11.6x |
| Thu, 05 Aug 2021 | zł2.6b | zł222.6m | -zł34,840,889.00 | 34.3x | -75.6x | 11.8x |
Price to Earnings Ratio
-128.3x
Current Industry PE
- Investors are relatively neutral on the Polish Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.7x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 25% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Polish Clinical Research and Equipment compare with similar industries?
| PL Market | 0.039% | |
| Healthcare | 1.59% | |
| Life Sciences | 0.25% | |
| Clinical Research and Equipment | 0.25% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł71.50 | 2.9% +zł36.7m | -7.7% | PE20.1x | |
| IGN Inno-Gene | zł1.79 | 5.0% +zł527.1k | -66.2% | PS23.4x |